PRACTITIONER 2009;253(1719):7

Weigh up the risks and benefits of IAD in prostate cancer

01 Jun 2009Pais-up subscribers

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article